MEDICINES DISCOVERY CATAPULT LIMITED: Contract Register & Procurement Profile
Companies House: PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)·North West England·Macclesfield
Companies House09928547 ↗
i
Tenders you can still bid for.
Notices at tender stage whose deadline has not passed, counted the way the search counts them: a notice shows under every code and region it names.
i
Notices published in the last 12 months.
Counted per tender, not per lot, against the 12 months before where shown.
i
How much of this buyer’s work goes to its three most frequent suppliers.
Share of its awarded tenders that name at least one of the top three. Each tender is counted once.
44 awarded tenders, 37 different suppliers.
Describes the record. It is not a sign of favouritism.
i
Contracts that finish in the next 18 months.
Published contracts with an end date in that window. No end date, not counted.
An end date does not confirm a new procurement.
i
How much this buyer has awarded recently, by published values.
Sum of published VAT-exclusive awards to single suppliers, last 24 months. Left out: concession revenue, framework ceilings, repeated notices, equal-value duplicates.
Published values, not actual spend. The biggest rows are listed so you can check.
What they buyi
What kind of work is bought here.
Notices by procurement category (CPV). A notice with several categories counts in each.
i
What kind of work is bought here.
Notices by procurement category (CPV). A notice with several categories counts in each.
Last 24 months · CPV divisions on published procedures · a notice with several divisions counts in each
73 Research and development services2 procedures · 7%79 Business services: law, marketing, consulting2 procedures · 7%38 Laboratory, optical and precision1 procedures · 3%48 Software package and information systems1 procedures · 3%How they buyi
How work here is packaged.
Notices by commercial tool: a single contract, a framework, or a dynamic purchasing system.
i
How work here is packaged.
Notices by commercial tool: a single contract, a framework, or a dynamic purchasing system.
Last 24 months · 30 notices · commercial tool and route as published on the notice, not a legal-regime claim
i
How work here is packaged.
Notices by commercial tool: a single contract, a framework, or a dynamic purchasing system.
Contract97%(29 notices)
29 of 30 notices are Contract (97%).Framework3%(1 notices)
1 of 30 notices are Framework (3%).
i
Which procedures buyers here use.
Notices by the procedure they declare: open, selective, limited or direct. Open and selective are competitions; limited and direct are not.
Direct award50%(15 notices)
15 of 30 notices are Direct award (50%).Limited / restricted27%(8 notices)
8 of 30 notices are Limited / restricted (27%).Open17%(5 notices)
5 of 30 notices are Open (17%).Selective3%(1 notices)
1 of 30 notices are Selective (3%).Route not published3%(1 notices)
1 of 30 notices are Route not published (3%).
i
How many companies usually bid when this buyer runs a tender.
Middle value of the bid counts on its award notices, one per lot. Only real competitions count: direct awards and framework places are left out.
Based on 1 lots from this buyer’s competitions, last 24 months. Small sample.
i
How often this buyer changes a notice after publishing it.
Middle number of amendments per notice. Deadline extensions and corrections both count.
Based on 30 notices across all categories, last 24 months.
Who wins herei
Which suppliers win the most here.
Suppliers ranked by the number of tenders won, not by money. A supplier on one big framework with many call-offs does not outrank one that won many separate competitions.
i
Which suppliers win the most here.
Suppliers ranked by the number of tenders won, not by money. A supplier on one big framework with many call-offs does not outrank one that won many separate competitions.
All published awards naming a supplier · ranked by distinct procedures, not pounds · panel and call-off entries inflate award records
| Supplier | Procedures | Share | Last 24m | Award records | Last activity |
|---|---|---|---|---|---|
| SOUTHERN SCIENTIFIC LIMITED | 3 | 6.8% | 2 | 3 | 17 Sept 2025 |
| Studylog | 2 | 4.5% | 2 | 2 | — |
| REINVIGORATION LTD | 2 | 4.5% | 2 | 2 | 20 Jan 2026 |
| SCI PARTNERS LLP | 2 | 4.5% | 1 | 2 | — |
| GlobalData UK Ltd | 2 | 4.5% | 1 | 2 | — |
| Thermo Electron Manufacturing Ltd t/a Thermo Fisher Scientific | 2 | 4.5% | 1 | 2 | — |
| Trustmarque Solutions Limited | 1 | 2.3% | 1 | 1 | — |
| Charles River UK | 1 | 2.3% | 1 | 1 | — |
The three most frequent suppliers are named on 16% of 44 awarded procedures (each procedure counted once, so a panel shared by several of them is not double-counted); 37 distinct suppliers hold at least one. Descriptive concentration of published awards, not a statement of preference.
i
How much this buyer has awarded recently, by published values.
Sum of published VAT-exclusive awards to single suppliers, last 24 months. Left out: concession revenue, framework ceilings, repeated notices, equal-value duplicates.
Published values, not actual spend. The biggest rows are listed so you can check.
i
The middle published award value for this buyer.
Middle value of the same awards as the total above.
Largest published awards iThe biggest published awards. Awards to a single supplier with a published value, largest first, so you can check the totals against the notice. A repeated framework total can appear here. Open the notice to check. | Supplier | Awarded | Term | Published value |
|---|---|---|---|---|
| Molecubes Preclinical SPECT Imager | SOUTHERN SCIENTIFIC LIMITED | 17 Sept 2025 | 1.3 yrs | £350,000 ≈ £280k/yr |
| Xenium Single-cell Spatial Transcriptomics/Proteomics Instrument for Medicines Discovery Catapult | 10X Genomics Inc. | 8 Dec 2025 | 1 yrs · up to 5 yrs | £344,000 ≈ £344k/yr |
| Electronic Laboratory Notebook (ELN) and Laboratory Information Management System (LIMS) | Collaborative Drug Discovery, Inc. | — | 3 yrs | £165,000 † ≈ £55k/yr |
| Recruitment of Transition Lead Role for Medicines Discovery Catapult | SCI PARTNERS LLP | — | 6 mo · up to 0.8 yrs | £160,000 † |
| Sample Management System | Azenta UK Ltd | — | 3 yrs · up to 5 yrs | £123,580 † ≈ £41k/yr |
Contracts endingi
Contracts that finish in the next 18 months.
Published contracts with an end date in that window. No end date, not counted.
An end date does not confirm a new procurement.
i
Contracts that finish in the next 18 months.
Published contracts with an end date in that window. No end date, not counted.
An end date does not confirm a new procurement.
Published end dates only · 23 of 42 contracts carry one · not a retender forecast
| Contract | Holder | Ends | Published value |
|---|---|---|---|
| Xenium Single-cell Spatial Transcriptomics/Proteomics Instrument for Medicines Discovery Catapult | 10X Genomics Inc. | 17 Dec 2026 | £344,000 |
| Multiplex Biomarker Discover Equipment | Merck Life Science UK Limited | 9 Jan 2027 | £128,634 |
| Online Webinar and Web Meeting Delivery Services for Medicines Discovery Catapult | Be There Global (UK) Limited | 9 Dec 2027 | £49,999 |
Recent procedures
Latest 50 of 75 procedures where this authority buys, is the authority the work is for, or runs the procurement
About this data
- Source. Official UK public procurement notices (Find a Tender), reused under the Open Government Licence v3.0. New notices arrive through the day; the figures are rebuilt nightly.
- One profile per authority. Different spellings and registration numbers of the same body are merged into this profile. It includes tenders the authority ran for other bodies and tenders run on its behalf; spend is credited to the body that pays.
- Values are published values. Award values are what the authority published, excluding VAT and framework ceilings. They are not a budget or total spend.
- Contract end dates. 23 of 42 published contracts state an end date; those feed “Contracts ending”.
- Every figure shows what it rests on. Not every notice publishes a bid count, a value or a delivery region, so each figure carries the number of records behind it, and one built on few records is marked as such. The on a figure explains it; the counting rules are in the methodology. Spotted something wrong? Tell us.